Erratum: BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase [Corrigendum]
Abstract
[This corrects the article on p. 179 in vol. 6, PMID: 25473312.].